Q1. I'm really puzzled by our chair's workload. He stepped up to chair our company in February 2024, but he's also chair of Australia's biggest duck producer, Love a Duck, executive chair of a private company called Charters Paper Pty Ltd but, most importantly, was appointed CEO of ASX listed SPC Global more than 12 months ago. How is all this possibly sustainable? I'm an unhappy shareholder in SPC Global where Robert is on a base salary of $630,000 to supposedly be the full time CEO. Yet here he is at Vitura Health being paid $156,000 a year to chair another poorly performing listed company. Also, why is he up for election again this year when we gave him a 3 year term at last year's AGM?
Answer: Dreadful question "paraphrasing" here by question wrangler "Tom" and then chair Iervasi sounded like a politician with his response. Watch video of exchange via Twitter.
Q2. Why was the resolution withdrawn yesterday to approve the issue of 74.8m shares at 6.9c to Charlie Shahin, raising $5.16 million in cash for the company? Were a majority of the proxy votes against, such that it was facing defeat? Is the effect of this that the selective placement remains on foot, we just have less placement capacity in the period ahead?
Answer: Very disappointing question censorship by “Tom” at the 38 minute meeting. Only lobbed two questions. The first above got butchered and this second one was ignored. Says something about the culture of the medicinal cannabis industry. Chair Robert Iervasi is meant to be full time CEO of SPC Global. Watch video of AGM being wrapped up via Twitter.
Copyright © 2025 The Mayne Report. All rights reserved